Corporate Finance

CP-DL Capolino-Perlingieri & Leone Advise on Sofinnova Partners and Fondazione Telethon Joint Venture

CP-DL Capolino-Perlingieri & Leone has advised Fondazione Telethon on the structuring of a joint venture with Sofinnova Partners, a leading European life-sciences venture capital fund, in relation to the formation of the Sofinnova-Telethon Fund, the first Italian fund on technology transfer entirely dedicated to the establishment of new Italian start-up companies in the biotech industry, focusing on  genetic/rare diseases.

CP-DL Capolino-Perlingieri & Leone has advised Fondazione Telethon on the structuring of a joint venture with Sofinnova Partners, a leading European life-sciences venture capital fund, in relation to the formation of the Sofinnova-Telethon Fund, the first Italian fund on technology transfer entirely dedicated to the establishment of new Italian start-up companies in the biotech industry, focusing on genetic/rare diseases.


With an initial funding of €50 million from the cornerstone investors – the European Investment Bank (EIB), the European Investment Fund (EIF) and Cassa Depositi e Prestiti (CDP) – and the objective of achieving an overall funding of between €75 and €100 million, the fund will finance Italian scientific research into genetic/rare diseases. In addition to the CP-DL Capolino-Perlingieri & Leone team (which included Giancarlo Capolino-Perlingieri, Maria Pia Carretta and Nicola Rapaccini), the law firms Arendt & Medernach (for EIF), Clifford Chance, Cooley and Legance for Sofinnova Partners, were also involved in this project.

interview

Accenture's CEO and CFO interview by Leaders League Group

About us

Download